| |
| |
|
| Insider
Information: |
Shak Steven |
| Relationship: |
Chief Scientific Officer |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
339,671 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$21,548,728 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
339,671 |
|
|
| Total
Value |
$21,548,728 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
Chief Scientific Officer |
2019-01-29 |
339,671 |
2019-11-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2019-03-01 |
4 |
OE |
$28.05 |
$701,250 |
I/I |
25,000 |
360,479 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2019-03-04 |
4 |
OE |
$28.05 |
$210,375 |
I/I |
7,500 |
342,979 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Medical Officer |
• – – |
2012-02-23 |
4 |
AS |
$28.14 |
$140,724 |
D/D |
(5,000) |
382,849 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D |
• – – |
2014-03-14 |
4 |
AS |
$28.36 |
$198,493 |
D/D |
(7,000) |
311,588 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-02-15 |
4 |
D |
$28.77 |
$39,933 |
D/D |
(1,388) |
332,380 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Medical Officer |
• – – |
2012-02-15 |
4 |
D |
$28.97 |
$18,222 |
D/D |
(629) |
387,849 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-12-17 |
4 |
AS |
$29.24 |
$204,671 |
D/D |
(7,000) |
308,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2019-01-30 |
4 |
OE |
$29.34 |
$733,500 |
I/I |
25,000 |
364,671 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2019-01-31 |
4 |
OE |
$29.34 |
$733,500 |
I/I |
25,000 |
364,671 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2017-02-23 |
4 |
AS |
$29.36 |
$146,815 |
D/D |
(5,000) |
331,103 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2017-02-23 |
4 |
AS |
$29.36 |
$146,815 |
D/D |
(5,000) |
331,103 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2017-05-23 |
4 |
AS |
$29.40 |
$146,981 |
D/D |
(5,000) |
331,103 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-10-15 |
4 |
AS |
$29.67 |
$148,341 |
D/D |
(5,000) |
308,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-12-16 |
4 |
AS |
$29.91 |
$209,350 |
D/D |
(7,000) |
308,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Medical Officer |
• – – |
2012-03-22 |
4 |
AS |
$30.08 |
$150,415 |
D/D |
(5,000) |
377,849 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2016-10-11 |
4 |
AS |
$30.39 |
$151,925 |
D/D |
(5,000) |
327,207 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2019-06-11 |
4 |
OE |
$30.84 |
$772,278 |
I/I |
25,000 |
258,479 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2019-06-12 |
4 |
OE |
$30.84 |
$773,768 |
I/I |
25,000 |
258,479 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2017-02-15 |
4 |
D |
$31.12 |
$89,750 |
D/D |
(2,884) |
331,103 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2019-06-13 |
4 |
OE |
$31.12 |
$778,000 |
I/I |
25,000 |
258,795 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2019-06-14 |
4 |
OE |
$31.12 |
$328,316 |
I/I |
10,550 |
244,345 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2017-03-23 |
4 |
AS |
$31.26 |
$156,295 |
D/D |
(5,000) |
331,103 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2016-11-10 |
4 |
AS |
$31.36 |
$158,569 |
D/D |
(5,000) |
327,207 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Chief Scientific Officer |
• – – |
2017-04-24 |
4 |
AS |
$31.46 |
$157,323 |
D/D |
(5,000) |
331,103 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D |
• – – |
2014-01-15 |
4 |
AS |
$31.51 |
$220,601 |
D/D |
(7,000) |
308,283 |
0 |
- |
|
170 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
